Patent ID: 8062625

Claim:
A method for selecting a subject for cancer immunotherapy comprising: determining the number of lymphocytes or neutrophils or both in the blood of a subject in need thereof; selecting a subject for immunotherapy when the number of lymphocytes is below or equal to a lymphocyte baseline level of 1.8×10 9 per liter blood, and/or when the number of neutrophils is below or equal to a neutrophil baseline level of 6.0×10 9 per liter blood; excluding a subject from immunotherapy when the number of lymphocytes is above a baseline level of 1.8×10 9 per liter blood and/or the number of neutrophils is above a baseline level of 6.0×10 9 per liter blood; providing immunotherapy to the selected subject; and not providing immunotherapy to the excluded subject.